Home / Inspections / 1118763

FDA Inspection 1118763 — Carter BloodCare

Carter BloodCare — FEI 3005680006

The FDA completed an inspection of Carter BloodCare on February 14, 2020 in Mansfield, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 14, 2020
Fiscal Year
2020
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Mansfield, TX (United States)

Facility

Other inspections at this facility

  • 1257153 (NAI Tue Dec 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1028502 (NAI Thu Oct 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 945067 (NAI Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 871498 (NAI Wed Mar 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 774031 (NAI Mon Mar 26 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources